The VEGF/VEGFR pathways play crucial roles in angiogenesis, with anti-VEGF treatments, like bevacizumab and faricimab, helping to prevent PC loss and stabilize microvascular networks. The gene discussed is VEGFA; the disease is pachyonychia congenita.